501126-37-0

Basic information

• Product Name: 4-(4-BOC-PIPERAZINO-1-YL)-3-FLUOROBENZALDEHYDE
• Synonyms: 4-(4-BOC-PIPERAZINO-1-YL)-3-FLUOROBENZALDEHYDE
• CAS NO: 501126-37-0
• Molecular Formula: C₁₆H₂₁FN₂O₃
• Molecular Weight: 308.351
• Mol File: 501126-37-0.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4-(4-BOC-PIPERAZINO-1-YL)-3-FLUOROBENZALDEHYDE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(4-BOC-PIPERAZINO-1-YL)-3-FLUOROBENZALDEHYDE(501126-37-0)
• EPA Substance Registry System: 4-(4-BOC-PIPERAZINO-1-YL)-3-FLUOROBENZALDEHYDE(501126-37-0)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 501126-37-0(Hazardous Substances Data)

Usage

General Description

4-(4-BOC-PIPERAZINO-1-YL)-3-FLUOROBENZALDEHYDE, also known as Boc-Pip-3-fluoro-benzaldehyde, is a chemical compound used in the synthesis of pharmaceuticals and organic compounds. It is commonly used as a building block for the creation of novel drug candidates and is known for its ability to modulate biological processes. 4-(4-BOC-PIPERAZINO-1-YL)-3-FLUOROBENZALDEHYDE is a key intermediate in the development of new chemical entities and has potential applications in the field of medicinal chemistry. With its unique structure and properties, 4-(4-BOC-PIPERAZINO-1-YL)-3-FLUOROBENZALDEHYDE plays an important role in the advancement of drug discovery and development.

Upstream product

• 34036-07-2 3,4 difluorobenzaldehyde 
• 57260-71-6 1-t-Butoxycarbonylpiperazine 
• 133059-43-5 4-bromo-3-fluorobenzaldehyde 

Downstream Products

• 935856-71-6 N,N-diethyl-2-[4-(2-fluoro-4-formyl-phenyl)-piperazin-1-yl]-2-phenyl-acetamide 

Relevant articles and documents

NOVEL COMPOUNDS AS INHIBITORS OF HISTONE DEACETYLASE 6 AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME

The present invention relates to a new compound having an inhibitory activity of histone deacetylase 6 (HDAC6), stereoisomers thereof, pharmaceutically acceptable salts thereof, a use thereof in the preparation of a drug, a pharmaceutical composition comprising them, a prophylactic or therapeutic method corresponding, and a method of preparing a new derivative 1,3,4-oxadiazole triazol, a novel compound having selective HDAC6 inhibitory activity being represented by the following chemical formula I.

Pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists

Compounds having the structural formula I or a pharmaceutically acceptable salt thereof, wherein R is optionally substituted phenyl, furanyl, thienyl, pyridyl, pyridyl N-oxide, oxazolyl or pyrrolyl, or cycloalkenyl R1, R2, R3, R4 and R5 are H, alkyl or alkoxyalkyl; and Z is optionally substituted aryl or heteroaryl are disclosed. Also disclosed is the use of compounds of formula I in the treatment of central nervous system diseases, in particular Parkinson's disease, alone or in combination with other agents for treating Parkinson's disease, and pharmaceutical compositions comprising them.